Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: Another piece to the atopic puzzle?

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 5, 2003, Pages 854-860

  Von Bubnoff, Dagmar ^a   Hanau, Daniel ^b   Wenzel, Joerg ^a   Takikawa, Osamu ^d   Hall, Brian ^c   Koch, Susanne ^a   Bieber, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Etablissement Francais Sang Alsace   (France)

^c MAYO CLINIC   (United States)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Antigen presenting cells; Fc RI; Immunoregulation; T cell suppression; Tryptophan degradation

Indexed keywords

CD123 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR6; FC RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; TRYPTOPHAN;

ANTIGEN PRESENTING CELL; ATOPY; DENDRITIC CELL; DISEASE ASSOCIATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TRYPTOPHAN METABOLISM;

EID: 0242550742     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(03)02014-1     Document Type: Article

References (44)

1. Widner B, Fuchs D. Immune activation and degradation of tryptophan. Modern Aspects of Immunobiology 2000;3:105-9.
2. Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999;20:469-73.
3. Fujigaki S, Saito K, Sekikawa K, et al. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur J Immunol 2001;31:2313-8.
4. Taylor MW, Feng GS. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB 1991;5:2516-22.
5. Aune TM, Pogue SL. Inhibition of tumor cell growth by interferon-γ is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. J Clin Invest 1989;84:863-75.
6. Munn DH, Sharma MD, Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002;297:1867-70.
7. Pfefferkorn ER. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A 1984;81:908-12.
8. Bodaghi B, Goureau O, Zipeto D, et al. Role of IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J Immunol 1999;15:957-64.
9. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-3.
10. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999;189:1363-71.
11. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000;164:3596-9.
12. Von Bubnoff D, Matz H, Frahnert C, et al. FcεRI induces the tryptophan degradation pathway involved in regulating T cell responses. J Immunol 2002;169:1810-6.
13. Yoshida R, Nukiwa T, Watanabe Y, Fujiwara M, Hirata F, Hayaishi O. Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice. Arch Biochem Biophys 1980;203:343-51.
14. Yamazaki F, Kuroiwa T, Takikawa O, Kido R. Human indolylamine 2,3-dioxygenase. 1st distribution, and characterization of the placental enzyme. Biochem J 1985;230:635-8.
15. Bonney EA, Matzinger P. Much IDO about pregnancy. Nat Med 1998;4:1128-9.
16. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997;7:445-50.
17. Grohmann U, Orabona C, Fallarino F, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002;3:I097-10I.
18. Van Kooten C, Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 1997;9:330-7.
19. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrata GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3.-dioxygenase. J Exp Med 2002;196:459-68.
20. Terness P, Bauer TM, Röse L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002;196:447-57.
21. Mac Kenzie CR, Gonzalez G, Kniep E, Roch S, Däubener W. Cytokine mediated regulation of interferon-gamma-induced IDO activation. In Huether G. Tryptophan, serotonin, and melatonin: basic aspects and applications. New York: Kluwer Academic/Plenum Publishers; 1999.
22. Von Bubnoff D, Geiger G, Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol 2001;108:329-39.
23. Chaves AC, Cerávolo IP, Gomes JA, Zani CL, Romanha AJ, Gazzinelli RT. IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-γ. Eur J Immunol 2001;31:333-44.
24. Weiss G, Murr C, Zoller H, et al. Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999;116:435-40.
25. Musso T, Gusella GL, Brooks A, Longo DL, Varesio L. Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 1994;83:1408-11.
26. Hu B, Hissong BD, Carlin JM. Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes. J Interferon Cytokine Res 1995;15:617-24.
27. Von Bubnoff D, Geiger E, Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol. 2001;108:329-39.
28. Novak N, Kraft S, Bieber T. Unraveling the mission of FcεRI on antigen-presenting cells. J Allergy Clin Immunol 2003;111:38-44.
29. Novak N, Kruse S, Kraft S, et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002;119:870-5.
30. Novak N, Tepel C, Koch S, Brix K, Bieber T, Kraft S. Evidence for a differential expression of the FcεRIγ chain in dendritic cells of atopic and nonatopic donors. J Clin Invest 2003;111:1047-56.
31. Maurer D, Ebner C, Reiniger B, et al. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J Immunol 1995;154:6285-90.
32. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol 2001;2:725-31.
33. Von Bubnoff D, Matz H, Cazenave JP, Hanau D, Bieber T, de la Salle H. Kinetics of gene induction after FcεRI ligation of atopic monocytes identified by suppression subtractive hybridization. J Immunol 2002;169:6170-7.
34. Leung DYM, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60.
35. Novak N, Bieber T, Katoh N. Engagement of FcεRI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 2001;167:797-804.
36. Grohmann U, Puccetti P. CTLA-4, T-helper lymphocytes and dendritic cells: an internal perspective of T-cell homeostasis. Trends Mol Med 2003;9:133-5.
37. Von Bubnoff D, Bezold G, Matz H, Hanau D, de la Salle H, Bieber T. Quantification of indoleamine 2,3-dioxygenase gene induction in atopic and nonatopic monocytes after ligation of the high affinity receptor for IgE, FcεRI, and Interferon-γ stimulation. Clin Exp Immunol 2003;132:247-53.
38. Carlin JM, Borden EC, Sondel PM, Byrne GI. Biologic response modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol 1987;139:2414-8.
39. Konan KV, Taylor MW. Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene. J Biol Chem 1996;32:19140-5.
40. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003;24:242-8.
41. Ye Q, Finn PW, Sweeney R, Bikoff EK, Riese RJ. MHC class II-associated invariant chain isoforms regulate pulmonary immune responses. J Immunol 2003;170:1473-80.
42. Kluken H, Wienker T, Bieber T. Atopic eczema/dermatitis syndrome - a genetically complex disease. New advances in discovering the genetic contribution. Allergy 2003;58:5-12.
43. Kerschenlohr K, Decard S, Przybilla B, Wollenberg A. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol 2003;111:869-74.
44. Dermott R, Ziylan U, Spehner D, et al. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Mol Biol Cell 2002;13:317-35.